NFKB1 and Parkinson disease: NAC can influence the activity of several transcription factors, including inhibition of NFκB [25], increased activation of NFκB has been observed in Parkinson's disease models [39]–[41], and inhibition of NFκB in glial cells has been proposed as a promising neuroprotective strategy [42].